Thiamin (vitamin B 1 ) is an essential micronutrient needed as a cofactor for many central metabolic enzymes. Animals must have thiamin in their diet, whereas bacteria, fungi, and plants can biosynthesize it de novo from the condensation of a thiazole and a pyrimidine moiety. Although the routes to biosynthesize these two heterocycles are not conserved in different organisms, in all cases exogenous thiamin represses expression of one or more of the biosynthetic pathway genes. One important mechanism for this control is via thiamin-pyrophosphate (TPP) riboswitches, regions of the mRNA to which TPP can bind directly, thus facilitating fine-tuning to maintain homeostasis. However, there is little information on how modulation of riboswitches affects thiamin metabolism in vivo. Here we use the green alga, Chlamydomonas reinhardtii, which regulates both thiazole and pyrimidine biosynthesis with riboswitches in the THI4 (Thiamin 4) and THIC (Thiamin C) genes, respectively, to investigate this question. Our study reveals that regulation of thiamin metabolism is not the simple dogma of negative feedback control. Specifically, balancing the provision of both of the heterocycles of TPP appears to be an important requirement. Furthermore, we show that the Chlamydomonas THIC riboswitch is controlled by hydroxymethylpyrimidine pyrophosphate, as well as TPP, but with an identical alternative splicing mechanism. Similarly, the THI4 gene is responsive to thiazole. The study not only provides insight into the plasticity of the TPP riboswitches but also shows that their maintenance is likely to be a consequence of evolutionary need as a function of the organisms' environment and the particular pathway used.
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eukaryotic riboswitch | gene expression coordination | metabolic regulation | cross-talk T hiamin (vitamin B 1 ) plays a vital role in all organisms as a cofactor for enzymes of glycolysis, the Krebs cycle, the pentose phosphate pathway, and the Calvin cycle in photosynthetic organisms. Animals are dependent on a source of thiamin in their diet, whereas microorganisms and plants can perform biosynthesis de novo. The biosynthesis of thiamin has two branches that culminate in the production of the heterocyclic moieties, hydroxyethylthiazole phosphate (HET-P) and hydroxymethylpyrimidine pyrophosphate (HMP-PP) (Scheme 1). These moieties are condensed to form thiamin monophosphate (TMP), which in eukaryotes is dephosphorylated by a phosphatase to form thiamin and is subsequently pyrophosphorylated by a pyrophosphokinase to the active cofactor thiamin pyrophosphate (TPP) (2, 3) . Despite the importance of thiamin, regulation of its metabolism is only beginning to be unraveled in eukaryotes.
In bacteria, fungi, algae, and plants, exogenous thiamin has been shown to regulate expression of some of the thiamin biosynthesis genes via sequences in the mRNA called riboswitches (4) (5) (6) (7) (8) (9) . Riboswitches comprise both an evolutionarily conserved metabolite sensing, or aptamer, domain and an expression platform that carries the gene regulatory signal (9) . Numerous studies have demonstrated that the cofactor form of vitamin B 1 , TPP, binds directly to the aptamer, inducing a conformational change that interferes with gene expression (9) (10) (11) (12) (13) . Several mechanisms for the modulation of gene expression have been described that reflect the diversity of control. For example, in bacteria, riboswitches are found in the 5′ untranslated region (UTR) of the corresponding mRNAs (14) , where either transcription termination or translation is affected in the presence of the metabolite. In eukaryotes, in contrast, expression is modulated through alternative splicing. Demonstrated examples of the latter include the fungi, Aspergillus oryzae (15) and Neurospora crassa (5); the green alga Chlamydomonas reinhardtii (6); and the plant Arabidopsis thaliana (4, 8, 16) . Interestingly, the location of the riboswitch varies in these organisms from being in an intron in the 5′-UTR, for example, in ThiA of Aspergillus (15) and THI4 of Chlamydomonas (6), to being in an internal intron in Chlamydomonas THIC (6), to being in an intron in the 3′-UTR in THIC of Arabidopsis (17) .
Intriguingly, with the discovery of thiamin riboswitches, it has emerged that there are no strict rules as to how many and which genes in the metabolic pathways are coupled to this RNA sensor. Our own analysis (based on a search at http://rfam.sanger.ac.uk) has revealed that many bacterial species can have from relatively few (e.g., two in Listeria monocytogenes) to several (e.g., Bacillus species are predicted to have eight) thiamin riboswitches, most of which are associated with genes involved in biosynthesis and transport. Eukaryotic organisms also vary; certain algae can have either one or two riboswitches (e.g., Thalassiosira pseudonana and Chlamydomonas, respectively) (6). Ancient plant taxa (e.g., bryophytes and lycophytes) also appear to have two riboswitches, whereas only one has been found in higher plants to date (4, 17) . In contrast, yeast has no riboswitches. Further complexity results from the fact that the biosynthesis pathways differ between organisms. Bacteria use intermediates derived from purine and isoprenoid biosynthesis for the pyrimidine and thiazole branches, respectively (18) , whereas the pathway in yeast uses B vitamin derivatives as precursors [specifically pyridoxal 5′-phosphate and nicotinamide adenine dinucleotide (NAD + )] (1, (19) (20) . Plants and Chlamydomonas use the bacterial pyrimidine route and make thiazole from NAD + and glycine (as shown in Scheme 1), and there is subcellular partitioning of the biosynthesis steps (2) . It has therefore been suggested that the riboswitch has been primarily acquired and maintained through a mechanism involving horizontal gene transfer (21, 22) .
Much has been deciphered of the molecular mechanism of thiamin riboswitches from analyses in vitro of TPP binding to the reconstituted aptamer domain (9-13). However, the requirement for these RNA sensors and their specific control over particular components of a thiamin metabolic pathway remains to be unraveled. In this context, Chlamydomonas provides a particularly amenable example because both the thiazole and pyrimidine branches are under riboswitch control, with riboswitches associated with the THI4 and THIC genes, respectively (6) . We have taken advantage of this system to perform an analysis in vivo of the response of thiamin biosynthesis in this organism upon perturbation of the pathway. Our results reveal a mechanism whereby balancing the provision of the heterocycle precursors emerges as a necessity for regulating thiamin metabolism in this organism. Furthermore, insight is revealed into the plasticity of the TPP riboswitch as a function of the particular pathway used.
Results
A Single Point Mutation in the THI4 Riboswitch Causes Thiamin Overaccumulation. To assess the effect of perturbation of the regulation of the thiamin biosynthesis pathway, we used the pyr1 mutant of Chlamydomonas, which is resistant to pyrithiamin, an antimetabolite that binds to TPP riboswitches. pyr1 has a single point mutation (C to U) in the P2 stem loop of the aptamer of the THI4 riboswitch (ref. 6 and Fig. 1A ), and this mutation has been shown to prevent TPP binding to the THI4 riboswitch in vitro (6) . Thus, this mutant serves as a tool for understanding how riboswitches regulate thiamin biosynthesis in Chlamydomonas. In the first instance, we measured the level of the B 1 vitamers (thiamin, TMP, and TPP) in pyr1 relative to the wildtype strain. Interestingly, all were found to be substantially higher (5-10-fold increase) in pyr1 compared with wild-type, with TPP being the most abundant vitamer (Fig. 1B) . Therefore, inactivation of the THI4 riboswitch results in the accumulation of considerably higher levels of B 1 vitamers. Furthermore, a quantitative analysis of the transcript level of THI4 and THIC under normal growth conditions revealed that although THI4 was more abundant, as expected in pyr1 compared with wild-type, so was THIC (Fig. 1C) . In other words, the presence of a functional riboswitch in THIC does not appear to respond to the overaccumulation of TPP observed in pyr1.
There Is a Natural Imbalance in THI4 and THIC Gene Expression. It has previously been shown that supplementation of Chlamydomonas cultures with thiamin results in an alternative splicing event that causes a decrease in the level of the functional THIC and THI4 transcripts (annotated THIC S and THI4 S , respectively) (6). We compared the sensitivity of the THIC and THI4 riboswitches by monitoring the response of the functional transcripts to supplementation with thiamin in the wild-type strain, using real-time quantitative PCR (qPCR). Even with low nanomolar quantities of thiamin, both THIC and THI4 responded to a similar extent ( Fig. 2A) . Moreover, the response of THIC in pyr1 was observed to be at least similar, if not more sensitive, to that of the wildtype under the same conditions (Fig. 2B ). As expected, THI4 did not respond to thiamin supplementation in pyr1. Given this, we were intrigued as to why THIC S expression was not decreased in pyr1. One explanation could be that THIC expression is controlled by an additional unknown factor when the thiazole branch, or at least the THI4 gene, is overexpressed, which would allow a good balance between the thiazole and the pyrimidine branches. Alternatively, the accumulated TPP in pyr1 is sequestered, preventing interaction with THIC pre-mRNA. However, we surmised that the THIC transcript level increases in pyr1 to balance the increased level of THI4; that is, both branches of the pathway are required to facilitate the biosynthesis of TPP. In this case, a higher level of TPP would be required to down-regulate Scheme 1. The thiamin biosynthesis pathway in Chlamydomonas. As in all organisms, TMP is generated from the condensation of HET-P and HMP-PP by the action of TMP synthase. THI4 catalyzes the formation of the thiazole moiety from NAD + , glycine, and the sulfur of a backbone cysteine residue (1) . THIM, which is a salvage enzyme in bacteria, is essential for thiazole production in Chlamydomonas. The pyrimidine moiety is biosynthesized from aminoimidazole ribonucleotide (AIR) via the action of THIC and THID. THID and TMP synthase enzyme activities are found in a single, bifunctional enzyme equivalent to TH1 in higher plants (3) . To generate the active cofactor, TPP, TMP is first dephosphorylated by an unknown phosphatase and then subsequently pyrophosphorylated by thiamin pyrophosphokinase (TPK). Both the THI4 and THIC genes are regulated through a TPP riboswitch (dashed line). THIC, as there is more present. A further implication is that there is cross-talk between the two branches of the pathway.
We then questioned whether both branches of the thiamin biosynthesis pathway are equally expressed. qPCR analysis of the level of THI4 and THIC gene expression in Chlamydomonas cells grown without supplementation demonstrated that THI4 is much more abundant (∼20-fold) than THIC (Fig. 2C ). This result is corroborated by several sets of publicly available RNAseq data (23) (24) (25) , in which the number of reads indicates a similarly disproportionate level in the abundance of the THI4 and THIC transcripts (Fig. 2D ).
Thiamin Precursor Intermediates Play an Active Part in Regulating the
Biosynthesis Pathway. These observations prompted us to probe the effect of the heterocyclic precursors on thiamin biosynthesis and growth of Chlamydomonas in more detail. Supplementation with either HET or HMP did not significantly change the B 1 vitamer profile of the wild-type culture (Fig. 3A) . As it is difficult to measure the precursors directly, we took advantage of thiamin-requiring mutants that are exclusively dependent on one or the other of the heterocycles for growth (26) to validate their uptake by Chlamydomonas. All mutants analyzed could grow in the presence of thiamin supplementation, but two mutants were restored to wild-type levels of growth by either HET (CC24) or HMP (CC25) supplementation alone (Fig. 3B) . As this confirmed that the precursors could be taken up, the effect of the precursors on expression of THIC and THI4 in the wild-type strain was assessed. Supplementation with HET significantly down-regulated expression of THI4 almost twofold (Fig. 3C) . A tendency for up-regulation of THIC was observed under the same conditions; however, it was not statistically significant compared with the nonsupplemented culture (Fig. 3C ). In contrast, supplementation with HMP caused a dramatic down-regulation of THIC expression (12-fold), whereas THI4 expression was not significantly changed (Fig. 3C) .
The alternative splicing of Chlamydomonas THIC pre-mRNA caused by thiamin supplementation results in a longer version of THIC mRNA (THIC L ) harboring a premature stop codon (Fig.  3D, Upper) , which prevents expression of a full-length and functional THIC protein (6) . In the context of these experiments, we checked whether a similar event occurs on supplementation with HMP. We observed a strong accumulation of the nonfunctional THIC L splicing variant in the presence of HMP (Fig.  3D, Lower) , and indeed, under our conditions, the amount of THIC L was more pronounced with HMP than with thiamin supplementation (Fig. 3D) . There was no significant change observed on HET supplementation. This implies that HMP supplementation induces a similar alternative splicing event to that observed with thiamin. Moreover, sequencing of the THIC splicing variant formed on HMP supplementation confirmed that it corresponds to THIC L (Fig. S1) . Furthermore, an immunochemical analysis using an antibody raised against Arabidopsis THIC demonstrated loss of the full-length THIC protein from Chlamydomonas on supplementation with HMP (or thiamin), but not with HET (Fig. 3E) . The higher mobility band observed with this antibody is specific for THIC, whereas the lower mobility band is nonspecific (Fig. 3E) . As the steady-state levels of TPP do not change when HMP is added to the algal culture (Fig.  3A) , these data suggest that THIC is responding directly to HMP.
HMP Specifically Regulates THIC Gene Expression Through the TPP
Riboswitch. To compare the response of THIC to HMP and thiamin supplementation, we performed a time course of expression on treatment with low nanomolar quantities of HMP; that is, levels that had been shown to induce a response with thiamin ( Fig. 2 A and B) . The expression of THI4 was monitored as a control. THIC responded to HMP within the first hour of treatment, similar to the response observed with thiamin (Fig.  4A) . In contrast, although the expression of THI4 was repressed by thiamin treatment, there was no effect on treatment with HMP under these conditions (Fig. 4B) . As it had previously been reported that HMP is not a ligand for the TPP riboswitch (27) , we sought to test whether HMP supplementation regulates THIC promoter activity. Therefore, we fused the 1,200-bp region immediately upstream of the start codon of THIC to the luciferase gene as a reporter construct and introduced this into Chlamydomonas. However, no significant effect on the luminescence of three independent transformed lines was observed in the presence of HMP (Fig. S2) . This was also the case for cultures grown in the presence of HET and thiamin as controls (Fig. S2) . It may thus be possible that HMP itself can bind to the THIC riboswitch in vivo. Indeed, a study probing TPP riboswitch ligand interactions with a series of analogs concluded that the riboswitch is most selective for the pyrimidine heterocycle (28), although HMP did not bind the aptamer domain in vitro (27) . However, it is noteworthy that the pyrophosphorylated form of HMP shares the key chemical features (i.e., pyrimidine and pyrophosphate; Scheme 1) that are considered to be essential for recognition by the TPP riboswitch (12, 13 ). Therefore, we tested whether it can bind to the Chlamydomonas riboswitch directly employing equilibrium dialysis, using the aptamer domain of the THIC riboswitch (Fig. S3) (Fig. 4C) . We also assessed whether HMP or HMP phosphate (HMP-P) could be better ligands than HMP-PP, using a competition assay by equilibrium dialysis. The results show that unlike TPP, neither HMP-P nor HMP could displace HMP-PP binding (Fig. S4) . In contrast, HMP-PP did not bind with any significance to the THI4 aptamer (Fig. 4C ). This may be accounted for by subtle ribonucleotide differences between the THI4 and THIC aptamer.
We sought to explore this further by testing the effect of the individual precursors on the THI4 riboswitch in vivo. The THI4 5′-UTR has been shown to be sufficient to cause repression of a gene fused downstream by the addition of exogenous thiamin (6, 29) . We generated Chlamydomonas lines expressing the THI4 5′-UTR fused to the bleomycin-resistance gene (30) . These lines are resistant to the antibiotic zeocin but die in the presence of thiamin and zeocin (Fig. 4D) . The addition of HMP had no effect, confirming the results from the equilibrium dialysis. Intriguingly, HET supplementation showed reduced zeocin resistance, which might indicate that this precursor had a direct effect on the THI4 gene. Notably, a similar effect on the transcript levels of the endogenous THI4 gene was observed earlier (Fig. 3C) .
Discussion
Several interesting points emerge in relation to thiamin metabolism and TPP riboswitches from this study of Chlamydomonas. First, it appears that a single point mutation in the THI4 riboswitch is sufficient to considerably increase B 1 vitamer levels in this alga. This is significant because a recent study in the model plant Arabidopsis showed that the equivalent mutation in the THIC riboswitch affects only the TMP levels, with a threefold change (31) . In our study on Chlamydomonas, all three vitamers are increased 5-10-fold (Fig. 1B) . Moreover, despite the substantial increases in the levels of the vitamers observed in the pyr1 mutant, there is no negative effect on the growth of the organism (Fig. S5) . Furthermore, supplementation with HMP and HET also increases the levels of the vitamers (Fig. S6 ) with no perturbation of growth observable (Fig. 3B) . This is in contrast to the Arabidopsis study, in which mutation of the riboswitch negatively affected metabolic homeostasis, resulting in chlorosis of the leaves, growth retardation, and delayed flowering. As in our study, there was enhanced expression of THIC in the Arabidopsis riboswitch mutant (31) . The authors suggest that this is because an increase in the activity levels of enzymes dependent on TPP leads to a stronger flux through central metabolism, resulting in higher carbohydrate oxidation that in turn severely In all supplementation cases, 10 μM of the respective compound was added. Values shown are the mean ± SD from three or more independent experiments. The asterisks indicate significant changes compared with no treatment and according to a Student t test. *P < 0.05; **P < 0.01; ***P < 0.001. influences plant physiology. However, it must be pointed out that considerable increases in the levels of TPP were not observed directly; rather, the maximal activity of certain TPP-dependent enzymes (i.e., pyruvate dehydrogenase and transketolase) was shown to increase (31) . Although the physiological effect of enhanced thiamin levels in Chlamydomonas needs to be studied in more detail, it could provide an interesting alternative to plants in certain contexts in which the vitamin is required as a commodity for fortification by supplementation.
Second, our data strongly suggest that HMP-PP itself binds to the THIC riboswitch, which has major implications not only for our understanding of the regulation of thiamin metabolism in general but also for the dogma associated with the mechanism behind this riboswitch. Several pieces of evidence collected within this study corroborate this statement: Supplementation with HMP causes a dramatic down-regulation of THIC expression, whereas it has no effect on THI4 expression under the same conditions, and moreover, the levels of TPP do not change from that without supplementation. Interestingly, the same alternative splicing event occurs on either HMP or thiamin supplementation, where the nonfunctional THIC L splicing variant accumulates with a corresponding loss in the level of the THIC protein (Fig. 3 D and E) . However, in vitro studies have shown that HMP itself does not bind to the riboswitch (27) , and our own studies here indicate that neither HMP nor HMP-P competes with HMP-PP binding. If we therefore assume that this also applies in vivo, then it is highly plausible that HMP is pyrophosphorylated by THID (32) and can bind to the riboswitch in a similar manner to TPP. Direct evidence that HMP-PP binds to the THIC riboswitch is provided by equilibrium dialysis (Fig. 4C) . The question now arises as to how selectivity for either HMP-PP or TPP arises in vivo. In this context, it is expected that both branches of the TPP biosynthesis pathway would be balanced to produce TPP efficiently. HMP-PP would only accumulate under circumstances in which there is an imbalance in the provision of HET-P. This statement is corroborated by our observations with the pyr1 mutant, in which the up-regulation of THI4 (as a consequence of the impaired riboswitch) is balanced with a concomitant up-regulation of THIC, resulting in higher levels of the thiamin vitamers. Notably, the accumulation of HET under these conditions could induce the up-regulation of THIC by decreasing the negative control of TPP, the mechanism of which needs further investigation. However, it is important to note that it has recently been demonstrated that the homolog of THI4 from Saccharomyces cerevisiae (THI4p) is a suicidal enzyme (1) . The HET moiety is assembled from glycine, NAD + , and sulfur from a backbone cysteine (Cys205) of the THI4p protein (1) . This cysteine and several other key catalytic residues are conserved in the Chlamydomonas THI4 (Fig. S7) , and therefore, a similar mechanism can be anticipated. Under these conditions, as THI4 can only catalyze a single turnover, its levels would be expected to be higher than those of THIC. Indeed, our own analysis here and the RNA-seq data of others ( Fig. 2 C and D) allow us to conclude that the THI4 transcript is in fact more abundant than that of THIC. Moreover, a previous proteomic study of Chlamydomonas was able to identify only THI4 among the thiamin biosynthetic enzymes, suggesting it was more abundant (33) . We propose, therefore, that in Chlamydomonas, the THIC riboswitch can recognize both HMP-PP and TPP as ligands because of the nature of its thiamin biosynthesis pathway. When both branches of the pathway are balanced, it is the build-up of TPP that will switch both branches off. However, if the production of HMP-PP by THIC is not balanced by an equal production of HET, then the recognition of HMP-PP by the riboswitch provides an additional checkpoint to switch off THIC expression. As THI4 is used up anyway in the provision of HET, such a short-circuit may not be required for this branch of the pathway. On the other hand, the effect of HET supplementation on the transcript levels of THI4 (Fig. 3C) and activity of the transgenic riboswitch (Fig.  4D) , albeit not as dramatic as with HMP on THIC, might argue for a similar feedback loop. In this context, a previous study using a WaterLOGSY (Ligand Observed via Gradient SpectroscopY) NMR provided evidence for weak binding of HET to the Escherichia coli thiM riboswitch (27) . Alternatively, the observed effect on THI4 expression in this study might be mediated by subtle alterations in metabolite levels. It is noteworthy that plants also use a homolog of THI4 (named THI1) for the biosynthesis of the HET moiety (Fig. S7) . However, although lower plants have a riboswitch controlling each branch of the pathway, similar to Chlamydomonas, higher plants have evolved to use just one riboswitch (i.e., that in THIC) to regulate the entire pathway. It must also be mentioned that the up-regulation of THIC in the pyr1 mutant, if as a consequence of the imbalance in the provision of HET, suggests crosstalk between both branches of the pathway.
In summary, we believe that this study of thiamin metabolism in vivo has revealed the plasticity of riboswitches and that the regulation of the biosynthesis of this compound is more complex than originally thought. The use of different pathways by different organisms for thiamin biosynthesis and the corresponding divergence in the number and mechanism of riboswitch controls provides an illuminating example of how this particular RNA sensor has evolved and adapted to the specific environment in which it operates. Future studies on the in vivo effect on modulation of riboswitches may further reveal their plasticity as a function of the particular environment and pathway used.
Materials and Methods
Strains and Media. C. reinhardtii (wild-type strain 12) was a gift from Jean David Rochaix, University of Geneva. The mutant pyr1 (CC1669) and thiaminrequiring mutants (CC23-CC25) were received from the Chlamydomonas Resource Center (http://chlamycollection.org), University of Minnesota 
